🇺🇸 United States Country × Condition
ovarian cancer Clinical Trials in United States
Active clinical trials for ovarian cancer with research sites in United States. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 25 // Recruiting: 25 Phases: Phase 2, Phase 1 // Updated: Daily
Total Trials
25
Recruiting Now
25
Country
🇺🇸 United States
Active Trials in United States (25)
NCT06906341 Phase 2
Recruiting
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Enrollment
270 pts
Country
🇺🇸 United States
Corcept Therapeutics
View Trial → NCT05103683 Phase 1
Recruiting
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Enrollment
90 pts
Country
🇺🇸 United States
TORL Biotherapeutics, LLC
View Trial → NCT05071937 Phase 2
Recruiting
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
Enrollment
33 pts
Country
🇺🇸 United States
Alexander B Olawaiye, MD
View Trial → NCT05739981 Phase 1, Phase 2
Recruiting
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Enrollment
30 pts
Country
🇺🇸 United States
Imunon
View Trial → NCT06305299 Phase 1
Recruiting
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Enrollment
27 pts
Country
🇺🇸 United States
UNC Lineberger Comprehensive Cancer...
View Trial → NCT05877599 Phase 1
Recruiting
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Enrollment
45 pts
Country
🇺🇸 United States
AstraZeneca
View Trial → NCT04520139 Phase 1, Phase 2
Recruiting
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Enrollment
102 pts
Country
🇺🇸 United States
University of California, Irvine
View Trial → NCT05983432 Phase 1
Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Enrollment
470 pts
Country
🇺🇸 United States
SystImmune Inc.
View Trial → NCT05113368 Phase 2
Recruiting
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
Enrollment
31 pts
Country
🇺🇸 United States
Sarah K. Lynam MD
View Trial → NCT06242470 Phase 1
Recruiting
A Study of MGC026 in Participants With Advanced Solid Tumors
Enrollment
250 pts
Country
🇺🇸 United States
MacroGenics
View Trial → NCT07564141 Phase 3
Recruiting
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
Enrollment
688 pts
Country
🇺🇸 United States
Genmab
View Trial → NCT05377996 Phase 1, Phase 2
Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Enrollment
360 pts
Country
🇺🇸 United States
Day One Biopharmaceuticals, Inc.
View Trial → NCT05000294 Phase 1, Phase 2
Recruiting
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Enrollment
29 pts
Country
🇺🇸 United States
University of Florida
View Trial → NCT04847063 Phase 1
Recruiting
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Enrollment
60 pts
Country
🇺🇸 United States
National Cancer Institute (NCI)
View Trial → NCT07424547 Phase 1
Recruiting
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Enrollment
386 pts
Country
🇺🇸 United States
Conjupro Biotherapeutics, Inc.
View Trial → NCT06840886 Phase 1
Recruiting
A Study of PHST001 in Advanced Solid Tumors
Enrollment
272 pts
Country
🇺🇸 United States
Pheast Therapeutics
View Trial → NCT06303505 Phase 1, Phase 2
Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Enrollment
250 pts
Country
🇺🇸 United States
Tubulis GmbH
View Trial → NCT06580002 Phase 2
Recruiting
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Enrollment
75 pts
Country
🇺🇸 United States
University of California, Irvine
View Trial → NCT01034033
Recruiting
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Enrollment
3,300 pts
Country
🇺🇸 United States
Stanford University
View Trial → NCT04606914 Phase 2
Recruiting
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Enrollment
70 pts
Country
🇺🇸 United States
University of Alabama at Birmingham
View Trial → NCT06910657 Phase 1
Recruiting
IDOV-Immune for Advanced Solid Tumors
Enrollment
78 pts
Country
🇺🇸 United States
ViroMissile, Inc.
View Trial → NCT06268665 Phase 2
Recruiting
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
Enrollment
86 pts
Country
🇺🇸 United States
University of California, Davis
View Trial → NCT07524322 Phase 1
Recruiting
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Enrollment
63 pts
Country
🇺🇸 United States
Regor Pharmaceuticals Inc.
View Trial → NCT07216105 Phase 1
Recruiting
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Enrollment
119 pts
Country
🇺🇸 United States
Fate Therapeutics
View Trial → NCT06695845 Phase 2
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Enrollment
200 pts
Country
🇺🇸 United States
Jazz Pharmaceuticals
View Trial → Frequently Asked Questions
How many ovarian cancer clinical trials are active in United States?
There are currently 25 active clinical trials for ovarian cancer with sites in United States, of which 25 are actively recruiting patients.
How can I join a ovarian cancer clinical trial in United States?
To join a ovarian cancer clinical trial in United States, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United States directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ovarian cancer trials in United States?
Active ovarian cancer trials in United States span Phase 2, Phase 1, Phase 1, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology